GLOBUS MEDICAL, INC. Proceeds from Collection of Notes Receivable
GLOBUS MEDICAL, INC. (GMED) reported Proceeds from Collection of Notes Receivable of $29.30 million for the 12-month period ending 2019-12-31, per its 10-K/A filed 2020-03-02.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfNotesReceivable · last filed 2021-02-17
- GLOBUS MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2019-12-31 was $0.00.
- GLOBUS MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2019-09-30 was $0.00.
- GLOBUS MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2019-06-30 was $0.00.
- GLOBUS MEDICAL, INC. proceeds from collection of notes receivable for the quarter ending 2019-03-31 was $29.30M.
- GLOBUS MEDICAL, INC. proceeds from collection of notes receivable for fiscal 2019 was $29.30M, a 0.00% change from fiscal 2018.
- GLOBUS MEDICAL, INC. proceeds from collection of notes receivable for fiscal 2018 was $29.30M.
| Period end | Proceeds from Collection of Notes Receivable 1 month | Proceeds from Collection of Notes Receivable 3 month | Proceeds from Collection of Notes Receivable 6 month | Proceeds from Collection of Notes Receivable 9 month | Proceeds from Collection of Notes Receivable 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | $29.30M 10-K/A · filed 2020-03-02 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $29.30M 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $29.30M 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | $29.30M 10-Q · filed 2019-05-02 | ||||
| 2018-12-31 | $29.30M 10-K · filed 2019-02-21 | ||||
| 2018-11-30 | $29.30M 10-K · filed 2021-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |